New Guardant Hereditary Cancer test offers germline testing to identify guideline-recommended genetic variants associated with cancer risk across 12+ tumor types Results help guide treatment decisions ...
ST. LOUIS, Oct. 16, 2025 /PRNewswire/ -- Mercy's Center for Precision Medicine is launching a new screening tool to identify those at high risk for cancer who may benefit from germline or hereditary ...
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022 Demand for germline hereditary cancer genetic testing has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback